Summary
- A Norwegian research team used aptamer-based proteomics to analyse blood samples from ME/CFS patients, identifying significant differences in 845 proteins compared to healthy controls.
- Dr Charles Shepherd, MEA Hon. Medical Adviser, provides a brief explanation, and notes that the MEA is currently assessing a research grant application for proteomics in ME/CFS.
On the 31st May, 2025, MedRxiv published a preprint of the paper, ‘Charting the Circulating Proteome in ME/CFS: Cross System Profiling and Mechanistic insights,' from a research group at the Norwegian research group led by Oystein Fluge and Olav Mella.
Extracts
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating condition often triggered by infections. The underlying mechanism remains poorly understood, and diagnostic markers and effective treatments are presently lacking.
We performed aptamer-based serum proteomics in 54 ME/CFS patients and 27 healthy controls and identified 1823 of 7326 aptamers reporting differences between the groups (845 after false discovery rate (FDR) correction).
Distinct patterns of tissue- and process-specific changes were seen. There was a broad increase in secreted proteins, while intracellular proteins, e.g. from skeletal muscle, particularly showed reduction.
Immune cell-specific signatures indicated immune reprogramming, including a distinct reduction in neutrophil-associated proteins. Focused secretome analysis supported intensified regulatory interactions related to immune activity, inflammation, vasculature, and metabolism. Validation of measurements using antibody-based methods confirmed findings for a selection of proteins.
The uncovered serum proteome patterns in ME/CFS patients help clarify a multifaceted pathophysiology and offer a foundation for future therapy and biomarker discovery efforts.
Comment from Dr Charles Shepherd:
Some interesting findings from the very reputable Norwegian research group headed by Oystein Fluge and Olav Mella.
The proteome is the entire set of body proteins. Proteomics is the study of the proteome – in particular the structure and function of these proteins, and the way in which they function and interact with each other inside cells.
The MEA is currently assessing a research grant application that will be assessing proteomics in ME/CFS.
Dr Charles Shepherd,
Trustee and Hon. Medical Adviser to the ME Association,
Member of the 2018-2021 NICE guideline on ME/CFS committee,
Member of the 2002 Chief Medical Officer's Working Group on ME/CFS
